Live from the NIH registry
Studies recruiting near Nampa right now
Top 25 of 253 recruiting studies, sorted by proximity — each links to its official registry page
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Phase 2
Interventional 500 participants sought
St. Lukes — Boise, Idaho (18.1 mi)
· Sponsor: Giselle Sholler
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Boise, Idaho (18.1 mi)
· Sponsor: Sameek Roychowdhury
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
St. Luke's Cancer Institute: Boise — Boise, Idaho (18.1 mi)
· Sponsor: Eli Lilly and Company
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
HPV, HPV - Anogenital Human Papilloma Virus Infection
N/A
Interventional 260 participants sought
ASR Idaho CGI — Boise, Idaho (18.1 mi)
· Sponsor: Mel Mont Medical
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Boise, Idaho Investigative Site 10073 — Boise, Idaho (18.1 mi)
· Sponsor: Colorado Prevention Center
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
St. Luke's Cancer Institute — Boise, Idaho (18.1 mi)
· Sponsor: Hoffmann-La Roche
ASSESS ALL ALS Study
Amyotrophic Lateral Sclerosis
N/A
Observational 2,000 participants sought
Saint Alphonsus Regional Medical Center — Boise, Idaho (18.1 mi)
· Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Phase 3
Interventional 300 participants sought
Humphreys Diabetes Center — Boise, Idaho (18.1 mi)
· Sponsor: Pfizer
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (18.1 mi)
· Sponsor: National Cancer Institute (NCI)
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Acute Respiratory Distress Syndrome, ARDS
Phase 3
Interventional 970 participants sought
Direct Biologics Investigational Site — Boise, Idaho (18.1 mi)
· Sponsor: Direct Biologics, LLC
A Study to Assess Growth in Children With Idiopathic Short Stature
Idiopathic Short Stature
N/A
Observational 300 participants sought
St. Luke's Children's Endocrinology — Boise, Idaho (18.1 mi)
· Sponsor: BioMarin Pharmaceutical
Long-Term Outcomes Following HBOT
Traumatic Brain Injury, Post-Concussive Symptoms
Phase 2
Interventional 35 participants sought
Summit Hyperbarics and Wellness — Boise, Idaho (18.1 mi)
· Sponsor: Summit Hyperbarics and Wellness
A Long-Term Follow-Up Study of Participants Exposed to REACT
Diabetic Kidney Disease, Chronic Kidney Diseases
N/A
Observational 80 participants sought
Boise Kidney & Hypertension Institute — Meridian, Idaho (8.8 mi)
· Sponsor: Prokidney
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Saint Luke's Cystic Fibrosis Center of Idaho — Boise, Idaho (18.1 mi)
· Sponsor: Nicole Hamblett
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Saint Luke's Cancer Institute - Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (3.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
St. Luke's Idaho Cardiology Associates — Meridian, Idaho (8.8 mi)
· Sponsor: Novo Nordisk A/S
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Pyoderma Gangrenosum
Phase 3
Interventional 90 participants sought
Ada West Research — Meridian, Idaho (8.8 mi)
· Sponsor: LEO Pharma
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
St Luke's Clinic - Neurology — Meridian, Idaho (8.8 mi)
· Sponsor: Pfizer
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Velocity Clinical Research - Boise — Meridian, Idaho (8.8 mi)
· Sponsor: Amgen
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Paradigm Clinical Research - Boise, ID — Boise, Idaho (18.1 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Cystic Fibrosis
Phase 1
Interventional 20 participants sought
St. Lukes CF Center of Idaho — Boise, Idaho (18.1 mi)
· Sponsor: Krystal Biotech, Inc.